20409 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine Non-condensed pyrazines
Compounds and compositions for delivering active agents
#902Non-Covalent Inhibitors of AmpC ß-Lactamase
#903TREATMENT OF VR1-ANTAGONIST-INDUCED INCREASE IN BODY TEMPERATURE WITH AN ANTIPYRETIC AGENT
#904USE OF SODIUM BLOCKERS FOR AN EARLY THERAPY OF OBSTRUCTIVE LUNG DISEASES
#905Compositions and methods for treating diabetes and neuropsychological dysfunction
#906METHOD FOR TREATING COGNITIVE DEFICITS
#907Methods and compositions for treating nephrogenic diabetes and insipidus
#908METHODS FOR THE TREATMENT OF BRAIN EDEMA
#909METHODS OF TREATING CNS DISORDERS
#910Treatment of neurodegenerative disorders with thiourea compounds
#911METHODS OF TREATING ISCHEMIC RELATED CONDITIONS
#912Antituberculous composition comprising oxazole compounds
#913ION CHANNEL MODULATING ACTIVITY II
#914INHIBITORS OF FATTY ACID AMIDE HYDROLASE
#915DI-T-BUTYLPHENYL PIPERAZINES AS CALCIUM CHANNEL BLOCKERS
#916Protection of ferulic acid and/or tetramethylpyrazine against retinal ischaemia, glaucoma and siderosis oculi
#917Use of drug combinations for treating insulin resistance
#918Sodium channel blockers
#919PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS
#920Heteroaryl-containing tripeptide HCV serine protease inhibitors
#921Pyrazine derivatives and uses thereof in renal monitoring
#922Topical formulations of Flucytosine
#923Anti-foot-and-mouth disease virus agent for animal belonging to family Suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family Suidae or sheep
#924PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS AND/OR TUMOR DISEASES BY INHIBITING PROTEIN FOLDING AND PROTEIN BREAKDOWN
#925Compositions and Methods for Treating Necrotizing Enterocolitis
#926Albumin Fusion Proteins
#927Albumin Fusion Proteins
#928Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
#929Therapeutic compositions for the treatment of cardiovascular diseases and methods for use therefor
#930METHODS OF USING SODIUM CHANNEL BLOCKERS
#931Methods and compositions for treating pulmonary hypertension and related diseases and disorders
#932CONTROLLED RELEASE TABLET FORMULATIONS FOR THE PREVENTION OF ARRHYTHMIAS
#933Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic
#934DRY PLATELET COMPOSITION
#935METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN
#936CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#937HUMAN N-TYPE CALCIUM CHANNEL BLOCKERS
#938Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
#939Method for Producing Adsorptive Porous Body
#940Methods of using and compositions comprising tryptophan hydroxylase inhibitors
#941METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS
#942New utilities of tricyclic compounds
#943Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction
#944PDE10 inhibitors and related compositions and methods
#945METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES
#946AMINOPYRAZINE ANALOGS FOR TREATING GLAUCOMA AND OTHER RHO KINASE-MEDIATED DISEASES AND CONDITIONS
#947AGENT FOR THE PROPHYLAXIS OR TREATMENT OF NEURODEGENERATIVE DISEASE
#948Use of Hdac Inhibitors for the Treatment of Myeloma
#949Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#950Albumin fusion proteins
#951Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis
#952Composition for Treating Hyperlipaemia
#953Selectively depolymerized galactomannan polysaccharide
#954TABLET COMPRISING EFLETIRIZINE AND PSEUDOEPHEDRINE
#955ALAPHATIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#956Uses of ion channel modulating compounds
#957CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#958SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
#959Capped pyrazinoylguanidine sodium channel blockers
#960CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#961Albumin Fusion Proteins
#962Albumin fusion proteins comprising insulin polypeptides
#963Albumin Fusion Proteins
#964Diagnosis and treatment of cancer related to human dormancy
#965REDUCTION OF CARDIOVASCULAR SYMPTOMS
#966Nitrogen-containing 5-membered ring compound
#967G-CSF-albumin fusion proteins
#968Albumin fusion proteins
#969Combination Therapy
#970Cathepsin K Inhibitors and Atherosclerosis
#971Methods and compositions for the treatment of cancer
#972Minicapsule Formulations
#973Methods and compositions for treating platelet-related disorders
#974COMBINATION THERAPY FOR THE TREATMENT OF PAIN
#975Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
#976METHODS FOR DETERMINING EFFECTIVE DOSES OF FATTY ACID AMIDE HYDROLASE INHIBITORS IN VIVO
#977Compounds That Inhibit Replication Of Human Immunodeficiency Virus
#978Sodium channel blockers
#979Modulation Of Neurotransmitter Activity In Neurons
#980Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#981Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
#982Composition and method to inhibit tissue plasminogen activator (tPA) - potentiated neurotoxicity
#983Treating Digestive Tract Conditions
#984Protection From And Treatment Of Prion Protein Infection
#985Combination Products
#986Benzamide derivatives and uses related thereto
#987Dihydropyrimidine Formulations
#988Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto
#989GASTRORETENTIVE SUSTAINED RELEASE FORMULATIONS
#990METHODS OF USING SODIUM CHANNEL BLOCKERS
#991Albumin fusion proteins
#992Aminocyclohexyl ether compounds and uses thereof
#993Crystalline solvate of glucokinase activator
#994Abnormal cannabidiols as agents for lowering intraocular pressure
#995Abnormal cannabidiols as agents for lowering intraocular pressure
#996Vinyl-phenyl derivatives for inflammation and immune-related uses
#997Albumin fusion proteins
#998Treatment of ischemia
#999Therapeutic Compounds: Pyridine as Scaffold
#1000Substituted Arylpyrazines
#1001Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
#1002Partial mGluR5 antagonists for treatment of anxiety and CNS disorders
#1003Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
#1004COMPOSITONS AND METHODS OF USE OF RITONAVIR FOR TREATING HCV
#1005Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
#1006HETEROCYCLIC MODULATORS OF PPAR
#1007Inhibition of tissue damage to skin from radiation treatment therapy
#1008Sustained release dosage forms of ziprasidone
#1009Methods of treating and preventing Alzheimer's disease
#1010Certain chemical entities, compositions and methods
#1011(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure
#1012Compositions for protection against superficial vasodilator flush syndrome, and methods of use
#1013Method of modulating ion channel functional activity
#1014Benzamide derivatives as p-38 kinase inhibitors
#1015Antifungal agent containing heterocyclic compound
#1016Aminocyclohexyl ether compounds and uses thereof
#1017Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#1018Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
#1019Phosphodiesterase 4 inhibitors
#1020Combinations of at1-antagonists, amiloride or triamterine, and a diuretic
#1021Substituted naphthalene sulfonamides
#1022New compounds
#1023Compounds
#1024Biaromatic ligand activators of PPARγ receptors
#1025Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
#1026Method for preparing peritoneal dialysate
#1027NPY Y5 antagonist
#1028Use of a trpm8-activating substance for the treatment of tumours
#1029METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS
#1030Treatment of VR1-antagonist-induced increase in body temperature with an antipyretic agent
#1031Albumin fusion proteins
#1032Methods for treatment of multiple sclerosis
#1033Nitrogen-containing 5-membered ring compound
#1034Treatment of protein degradation disorders
#1035Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
#1036Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers
#1037Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor
#1038Capped pyrazinoylguanidine sodium channel blockers
#1039Ion channel modulating activity II
#1040Methods of treating ischemic related conditions
#1041Albumin fusion proteins
#1042Identification of compounds that inhibit replication of human immunodeficiency virus
#1043Dosage form and method for sustained release of substituted pyrazine compound
#10442-amido pyrazines for inflammation and immune related uses
#1045Water-stabilized aerosol formulation system and method of making
#1046Compounds and compositions for delivering active agents
#1047Methods of treating ischemic related conditions
#1048Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound
#1049Hetero substituted sodium channel blockers
#1050Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
#1051Sodium channel blockers
#1052Compositions comprising multiple bioactive agents, and methods of using the same
#1053Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
#1054Ion channel modulating activity I
#1055Pyrazine based inhibitors of glycogen synthase kinase 3
#1056Stable dispersion of solid particles comprising a water-insoluble pyrazine compound
#1057Tablet comprising efletirizine and pseudoephedrine
#1058Synthetic process for trans-aminocyclohexyl ether compounds
#1059Use of tetramethylpyrazine in the treatment of brain tumor
#1060Encapsulated pharmaceutical agents
#1061Pharmaceutical composition for regeneration of cirrhotic liver
#1062Sodium channel blockers
#1063Capped pyrazinoylguanidine sodium channel blockers
#1064Capped pyrazinoylguanidine sodium channel blockers
#1065Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
#1066Diketopiperazine salts for drug delivery and related methods
#1067Immunomodulation and effect on cell processes relating to serotonin family receptors
#1068Antineoplastic combinations
#1069Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#1070Ccr4 antagonist and medical use thereof
#1071Medicinal compositions containing diuretic and insulin resistance-improving agent
#1072Sleep inducing compounds and methods relating thereto
#1073Method for preparing peritoneal dialysate
#1074Compounds which inhibit leukocyte adhesion mediated by VLA-4
#1075Method and formula for anti-tumor and anti-matastatic effect
#1076Antimycobacterial pharmaceutical composition
#1077Stabilized short-course chemotherapy (SCC) anti-tuberculosis drug compositions
#1078Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
#1079Inhibitors of fatty acid amide hydrolase
#1080Capped pyrazinoylguanidine sodium channel blockers
#1081Capped pyrazinoylguanidine sodium channel blockers
#1082Methods and compositions for treating platelet-related disorders
#1083Composition for protection against superficial vasodilator flush syndrome
#1084Substituted arylpyrazines
#1085Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#1086Antineoplastic combinations
#1087Albumin fusion proteins comprising GLP-1 polypeptides
#1088Methods and systems for inhibiting arrhythmia
#1089Enhancing the efficacy of tubercular drugs
#1090Combination of a cdk inhibitor and 5-fu for the tratment of cancer
#1091Biaromatic ligand activators of PPARγ receptors
#1092Ion channel modulating activity method
#1093Composition
#1094Methods for treating ACAT-related diseases
#1095Sodium channel blockers
#1096Sodium channel blockers
#1097Sodium channel blockers
#1098Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
#1099Identification of compounds that inhibit replication of human immunodeficiency virus
#1100Methods of reducing risk of infection from pathogens
#1101Methods of reducing risk of infection from pathogens
#1102Capped pyrazinoylguanidine sodium channel blockers
#1103Ion channel modulating activity I
#1104Nitrogenous 5-membered ring compounds
#1105Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
#1106Synthetic process for trans-aminocyclohexyl ether compounds
#1107Uses of ion channel modulating compounds
#1108p-38 kinase inhibitors
#1109Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment
#1110Treatment of a lionfish sting and formulations for use thereof
#1111Treatment of protein degradation disorders
#1112Antiprotozoal amidine compounds